Tag Archive for: Roel Bulthuis

Trends in life science investments – Top take-aways from Anglonordic

The first panel of the day, chaired by Mary Clark, our co-founder and CEO, saw a group of Europe’s leading investors – Hakan Goker, M Ventures; Maina Bhaman, Sofinnova Partners; Christian Elling, Lundbeckfonden; and Roel Bulthuis, Syncona – share sage advice for companies looking to raise funds, providing insights on the most important factors shaping […]

An Overview of Optimum’s 14th Annual Healthcare Investor Conference 2022

Two weeks ago, Optimum hosted its 14th Annual Healthcare Investor Conference and wow, what a fantastic event it was! After two years of disruption, we were delighted to be meeting again in person. While virtual meetings have been a fantastic boon during these difficult times, nothing can beat meeting and sharing ideas and opinions face-to-face, […]

VC Investor Panel: Building the Future Champions 

Watch a replay of the live session here or read our top takeaways below…

Investor Q&A Series: Roel Bulthuis, INKEF Capital

In our first Investor Q&A article, Roel Bulthuis, Managing Partner of INKEF Capital shares his thoughts on the investment landscape in Europe.

If I Knew Then, What I Know Now

Mike Ward, Global Head of Thought Leadership at Decision Resources Group, part of Clarivate, chaired a panel of top industry executives at the Anglonordic Life Sciences Conference:   Renee Aguiar-Lucander, CEO Calliditas Therapeutics, Steven Powell, CEO eTheRNA immunotherapies and Roel Bulthuis, Managing Partner at INKEF Capital, shared key decisions that shaped the fate of their various […]